{
    "title": "Pfizer keeps COVID sales forecast unchanged as pandemic curbs ease",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10778207/Pfizer-keeps-sales-forecast-COVID-antiviral-pill-unchanged.html",
    "date": "2022-05-03",
    "keywords": [
        "vaccine",
        "pfizer",
        "year",
        "covid19",
        "company",
        "forecast",
        "erman",
        "growth",
        "covid",
        "treatment",
        "paxlovid",
        "drug",
        "quarter",
        "analyst",
        "authorization",
        "age",
        "june",
        "tuesday",
        "series",
        "revenue",
        "sign",
        "masking",
        "expectation",
        "fraction",
        "companys",
        "reluctance",
        "dearth",
        "biontech",
        "se",
        "demand",
        "usage",
        "executive",
        "albert",
        "bourla",
        "interview",
        "weve",
        "uncertainty",
        "ability",
        "research",
        "note",
        "share",
        "firstquarter",
        "stock",
        "rise",
        "extent",
        "beat",
        "intelligence",
        "bit",
        "gray",
        "food",
        "administration",
        "group",
        "update",
        "omicron",
        "variant",
        "coronavirus",
        "protection",
        "fall",
        "reporting",
        "bengaluru",
        "michael",
        "jersey",
        "editing",
        "chakrabarty",
        "bernadette",
        "baum",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}